These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36336817)

  • 1. Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectives.
    Goto A; Yamamoto S; Iwasaki S
    Biopharm Drug Dispos; 2023 Feb; 44(1):26-47. PubMed ID: 36336817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.
    Monine M; Norris D; Wang Y; Nestorov I
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):639-654. PubMed ID: 33991294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric nanoparticles for drug delivery to the central nervous system.
    Patel T; Zhou J; Piepmeier JM; Saltzman WM
    Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.
    Biddlestone-Thorpe L; Marchi N; Guo K; Ghosh C; Janigro D; Valerie K; Yang H
    Adv Drug Deliv Rev; 2012 May; 64(7):605-13. PubMed ID: 22178615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.
    Vuillemenot BR; Korte S; Wright TL; Adams EL; Boyd RB; Butt MT
    Toxicol Sci; 2016 Jul; 152(1):3-9. PubMed ID: 27354708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal delivery of biologics to the central nervous system.
    Lochhead JJ; Thorne RG
    Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimer advances for the central nervous system delivery of therapeutics.
    Xu L; Zhang H; Wu Y
    ACS Chem Neurosci; 2014 Jan; 5(1):2-13. PubMed ID: 24274162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarriers for Delivery of Oligonucleotides to the CNS.
    Male D; Gromnicova R
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnologies: a strategy to overcome blood-brain barrier.
    De Rosa G; Salzano G; Caraglia M; Abbruzzese A
    Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal drug delivery to the central nervous system: present status and future outlook.
    Tayebati SK; Nwankwo IE; Amenta F
    Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal delivery to the central nervous system: mechanisms and experimental considerations.
    Dhuria SV; Hanson LR; Frey WH
    J Pharm Sci; 2010 Apr; 99(4):1654-73. PubMed ID: 19877171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
    Goyal K; Koul V; Singh Y; Anand A
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS drug delivery systems: novel approaches.
    Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and local drug delivery for treating diseases of the central nervous system in rodent models.
    Serwer L; Hashizume R; Ozawa T; James CD
    J Vis Exp; 2010 Aug; (42):. PubMed ID: 20736920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal delivery of protein therapeutics to the brain: a critical reassessment.
    Calias P; Banks WA; Begley D; Scarpa M; Dickson P
    Pharmacol Ther; 2014 Nov; 144(2):114-22. PubMed ID: 24854599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agile delivery of protein therapeutics to CNS.
    Yi X; Manickam DS; Brynskikh A; Kabanov AV
    J Control Release; 2014 Sep; 190():637-63. PubMed ID: 24956489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CNS as a target for peptides and peptide-based drugs.
    Banks WA
    Expert Opin Drug Deliv; 2006 Nov; 3(6):707-12. PubMed ID: 17076593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases.
    Mansor NI; Nordin N; Mohamed F; Ling KH; Rosli R; Hassan Z
    Curr Drug Deliv; 2019; 16(8):698-711. PubMed ID: 31456519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
    Crawford L; Rosch J; Putnam D
    J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.